Tyrian Diagnostics Limited (TDX)-Product Pipeline Analysis, 2016 Update

Tyrian Diagnostics Limited (TDX)-Product Pipeline Analysis, 2016 Update


  • Products Id :- GDME6475PD
  • |
  • Pages: 22
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Tyrian Diagnostics Limited (Tyrian Diagnostics) formerly Proteome Systems Limited is a medical equipment company that manufactures, and markets diagnostics for clinical and non-clinical applications. The company discovers and validates novel biomarkers for tuberculosis. It has developed a proprietary point of care diagnostics platform such as diagnostiQTM. Tyrian also develops various solutions for proteomics research. The company's technology comprises small disposable plastic capsule and a USB-driven reader machine. It distributes its product through partnerships with various marketing and distribution companies. Tyrian Diagnostics is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Tyrian Diagnostics Limited

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Tyrian Diagnostics Limited Company Snapshot 5

Tyrian Diagnostics Limited Company Overview 5

Tyrian Diagnostics Limited Pipeline Products and Clinical Trials Overview 6

Tyrian Diagnostics Limited-Pipeline Analysis Overview 8

Key Facts 8

Tyrian Diagnostics Limited-Major Products and Services 9

Tyrian Diagnostics Limited Pipeline Products by Development Stage 10

Tyrian Diagnostics Limited Pipeline Products Overview 12

Biomarker Test-Cystic Fibrosis 12

Biomarker Test-Cystic Fibrosis Product Overview 12

Prostate cancer diagnostic test using HCA 13

Prostate cancer diagnostic test using HCA Product Overview 13

Prostate Cancer Diagnostic Test using HCA 14

Prostate Cancer Diagnostic Test using HCA Product Overview 14

Second Generation TB POC Test 15

Second Generation TB POC Test Product Overview 15

Tyrian Diagnostics Limited-Key Competitors 16

Tyrian Diagnostics Limited-Key Employees 17

Tyrian Diagnostics Limited-Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Tyrian Diagnostics Limited, Recent Developments 19

Dec 19, 2011: Tyrian Signs Distribution Agreement For Tuberculosis Antibodies 19

Nov 24, 2011: Tyrian Diagnostics Announces Resignation Of Michael Vamos As CFO 19

Oct 15, 2009: Tyrian Seeks New Partner Opportunities For Tuberculosis Diagnostic Tests 19

Apr 30, 2009: Tyrian Announces Resignation Of Phillip Morley From Its Board 20

Nov 06, 2008: Proteome Systems Changes Its Name To Tyrian Diagnostics 20

Aug 29, 2008: Proteome Systems Reports Fiscal Year 2008 Results 20

Jul 16, 2008: Proteome Systems Reports Proof Of Concept Study Results For Prostate Cancer Diagnostic Program 20

Feb 29, 2008: Proteome Systems Reports 1H Fiscal 2008 Results 20

Jun 19, 2007: Proteome Systems Appoints New Directors 21

May 02, 2007: Proteome Systems Appoints New CEO 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22

List of Figures

Tyrian Diagnostics Limited Pipeline Products by Equipment Type 7

Tyrian Diagnostics Limited Pipeline Products by Development Stage 10

List of Tables

Tyrian Diagnostics Limited Pipeline Products and Clinical Trials Overview 6

Tyrian Diagnostics Limited Pipeline Products by Equipment Type 6

Tyrian Diagnostics Limited Pipeline Products by Indication 7

Tyrian Diagnostics Limited, Key Facts 8

Tyrian Diagnostics Limited, Major Products and Services 9

Tyrian Diagnostics Limited Number of Pipeline Products by Development Stage 10

Tyrian Diagnostics Limited Pipeline Products Summary by Development Stage 11

Biomarker Test-Cystic Fibrosis-Product Status 12

Biomarker Test-Cystic Fibrosis-Product Description 12

Prostate cancer diagnostic test using HCA-Product Status 13

Prostate cancer diagnostic test using HCA-Product Description 13

Prostate Cancer Diagnostic Test using HCA-Product Status 14

Prostate Cancer Diagnostic Test using HCA-Product Description 14

Second Generation TB POC Test-Product Status 15

Second Generation TB POC Test-Product Description 15

Tyrian Diagnostics Limited, Key Employees 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Phylogica Limited

Nusep Holdings Limited

Biotron Limited

Tyrian Diagnostics Limited, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 48428
Site License
USD 1500 INR 96855
Corporate User License
USD 2250 INR 145283

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com